Pacira BioSciences, Inc. PCRX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s retained earnings?
- Pacira BioSciences, Inc. (PCRX) reported retained earnings of -$196.41M in Q1 2026.
- How has Pacira BioSciences, Inc.'s retained earnings changed year-over-year?
- Pacira BioSciences, Inc.'s retained earnings increased by 2.5% year-over-year, from -$201.54M to -$196.41M.
- What is the long-term trend for Pacira BioSciences, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s retained earnings has grown at a -4.7% compound annual growth rate (CAGR), from -$253.88M to -$199.32M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.